[Event Report] Special International Forum: The Importance of Vaccines and Japan’s Role in Global Health (October 22, 2021)
date : 11/1/2021
Tags: Vaccinations
Health and Global Policy Institute (HGPI) convened an online Special International Forum: “The Importance of Vaccines and Japan’s Role in Global Health.”
The importance of vaccines in the context of global health has started to take up more space in the vaccine policy debate than ever before. As the impact of COVID-19 is felt in developing, as well as developed countries, a global, collaborative framework (ACT-A: Access to COVID-19 Tools Accelerator) to accelerate access to tools related to COVID-19 has been launched. Through the COVAX Facility, a multilateral framework for the procurement and distribution of safe and approved vaccines has been established. Furthermore, international contributions are being made through bilateral vaccine donations. Japan has engaged in various international cooperation initiatives through its Strategy on Global Health Diplomacy, approved by the Cabinet in 2013, and the Basic Design for Peace and Health (Global Health Cooperation), created in 2015.
At the same time, the international supply of COVID-19 vaccines has been unevenly distributed, with middle- and high-income countries receiving more vaccines and low-income countries receiving far fewer. Recently, there have been calls around the world for vaccines to be classified as “Global Public Goods” and it is essential that we expand the conversation to promote public and stakeholder interest and understanding of international contributions and diplomatic issues related to COVID-19.
The Special International Forum focused on Japan’s global provision of COVID-19 vaccines, the COVAX Facility’s current status and prospects, and Japan’s future role in health diplomacy. Experts from industry, government, academia, and the private sector in Japan and abroad engaged in discussions on the significance of medicines, including vaccines, to global health and the role expected of Japan moving forward.
■Date: Friday, October 22, 2021, 15:30-18:00 JST
■Format: Zoom Webinar
■Participation Fee: Free
■Language: English and Japanese (simultaneous interpretation available)
■Host: Health and Global Policy Institute
■Co-host: The British Embassy Japan
■Program: (Titles omitted)
15:30-15:35 Opening Address (1)
Kiyoshi Kurokawa (Chairman, Health and Global Policy Institute)
15:35-15:40 Opening Address (2)
Julia Longbottom (British Ambassador to Japan)
15:40-15:45 Event Overview
Ryoji Noritake (CEO & Board Member, Health and Global Policy Institute)
15:45-16:00 Keynote Speech (1) Lessons Learned from UK’s Vaccine Rollout and Global Health Strategy
Saul Walker (Deputy Head of COVID-19 Vaccines, Therapeutics and Diagnostics Strategy, Foreign Commonwealth and Development Office(FCDO), UK)
16:00-16:15 Keynote Speech (2) Japan’s International Collaboration Efforts in the COVID-19 Era
Satoshi Ezoe (Director, Global Health Policy Division, Ministry of Foreign Affairs, Japan)
Panelists:
Mihoko Kashiwakura (Head of East Asia Relations, Bill & Melinda Gates Foundation)
Keizo Takemi (Member of the House of Councilors; WHO Goodwill Ambassador for UHC)
Atsushi Sunami (President, The Sasakawa Peace Foundation)
Kayo Takuma (Professor, Tokyo Metropolitan University)
Suwit Wibulpolprasert (Senior Advisor, Thai Ministry of Health)
Moderator:
Joji Sugawara (Manager, Health and Global Policy Institute)
17:50-18:00 Closing Remarks
Noriko Furuya (Member of the House of Representatives; Acting Chairperson, Association for the Promotion of Improved Public Health, Parliamentary Group for Vaccines and Prevention)
*Please find out the brochure at the bottom of this website for more information.
日本語
Top Research & Recommendations Posts
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Policy Recommendations] Establishing an Integrated Care System for Pain from the Perspectives of People with Lived Experience (March 29, 2024)
- [Announcement] Participation in an International Survey on Brain Health for Young People “The Next Generation (NextGen) Brain Health Research Program” (July 1, 2024)
- [Japanese Version Release] “Call for Actionable Steps in Response to the Rising Threat of Antimicrobial Resistance (AMR)” (July 3, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
Featured Posts
-
2024-07-01
[Registration Open] Meaningful Involvement Promotion Project Online Expert Meeting “Shaping the Future of Health Policy with People with Lived Experience and Citizens” (July 26, 2024)
-
2024-07-17
[Event Report] Non-partisan Diet Member Briefing – 30-minute Health Policy Update: “Towards Overcoming Kidney Disease: Strengthening Measures Against CKD” (June 7, 2024)
-
2024-07-18
[Registration Open] (Hybrid Format) Kidney Disease Control Promotion Project Public Symposium “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” (August 28, 2024)
-
2024-07-22
[HGPI Policy Column] No. 44 — From the Planetary Health Policy Project, Part 9 “Connecting Climate Minds: the Intersection of Climate Change and Mental Health”
-
2024-07-23
[Registration Open] (Webinar) HGPI Special Seminar “The Emerging Threat of Antifungal Resistance — Considering Infectious Diseases Caused by Mold and Measures to Combat Drug Resistance” (August 23, 2024)